Creative Medical Technology Holdings, Inc. (CELZ) vs Kairos Pharma, Ltd. (KAPA)

Creative Medical Technology Holdings, Inc. and Kairos Pharma, Ltd. are both Biotechnology companies. Creative Medical Technology Holdings, Inc. and Kairos Pharma, Ltd. are of similar size ($6.4M and $6.1M). Across the 9 metrics below, Creative Medical Technology Holdings, Inc. leads on 7 and Kairos Pharma, Ltd. on 2.

Valuation

Metric CELZ KAPA Biotechnology median
P/E n/m n/m 7.88
P/S 222.10 n/m 11.47
P/B 0.44 1.26 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.38 n/m 0.74
EV/Sales (136.42) n/m 10.73
Earnings yield (202.94%) (113.92%) (28.84%)
Free cash flow yield (297.24%) (75.40%) (23.03%)

Profitability

Metric CELZ KAPA Biotechnology median
Gross margin 61.18% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (77.91%) (113.96%) (57.72%)
Return on assets (73.30%) (104.32%) (49.22%)
Return on invested capital 0.00% (322.91%) 0.00%

Growth

Metric CELZ KAPA Biotechnology median
Revenue growth (TTM) (79.42%) — 5.64%
EPS growth (last fiscal year) 32.08% (30.44%) —
Revenue growth, 5-year CAGR (48.43%) — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CELZ KAPA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 12.91 11.98 4.73
Net debt to EBITDA 1.20 1.65 0.96

Dividend

Metric CELZ KAPA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric CELZ KAPA Biotechnology median
Market cap 6.36m 6.13m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack